Sujoy Khan
Ibrutinib does not reverse disease- and treatment-related hypogammaglobulinaemia associated with chronic lymphocytic leukemia
Khan, Sujoy; Durairaj, Senthilkumar; Phumphukhieo, Punyarat; Holding, Stephen; Allsup, David
Authors
Senthilkumar Durairaj
Punyarat Phumphukhieo
Stephen Holding
Professor David Allsup D.J.Allsup@hull.ac.uk
Professor of Haematology
Citation
Khan, S., Durairaj, S., Phumphukhieo, P., Holding, S., & Allsup, D. (2021). Ibrutinib does not reverse disease- and treatment-related hypogammaglobulinaemia associated with chronic lymphocytic leukemia. Leukemia & Lymphoma, 1-8. https://doi.org/10.1080/10428194.2021.1885662
Journal Article Type | Letter |
---|---|
Acceptance Date | Jan 28, 2021 |
Online Publication Date | Feb 17, 2021 |
Publication Date | Feb 17, 2021 |
Deposit Date | Feb 18, 2021 |
Publicly Available Date | Feb 18, 2022 |
Journal | Leukemia and Lymphoma |
Print ISSN | 1042-8194 |
Electronic ISSN | 1029-2403 |
Publisher | Taylor and Francis |
Peer Reviewed | Peer Reviewed |
Pages | 1-8 |
DOI | https://doi.org/10.1080/10428194.2021.1885662 |
Keywords | Cancer Research; Oncology; Hematology |
Public URL | https://hull-repository.worktribe.com/output/3726327 |
Ensure healthy lives and promote well-being for all at all ages
Files
Article
(109 Kb)
PDF
Copyright Statement
©2021 The authors. All rights reserved. No part of this publication may be reproduced without the written permission of the copyright holder
You might also like
Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia
(2025)
Journal Article
Fixed Duration Ibrutinib‐Venetoclax, a Redefinition of the CLL Treatment Landscape
(2025)
Journal Article
Chronic Lymphocytic Leukemia Care and Beyond: Navigating the Needs of Long-Term Survivors
(2025)
Journal Article